where am I confused 222 bopd X $100/bo X 365 days equals 81million exactly how is that uneconomical??
do you really mean "dearth" which is a lack of information. I expect lots of information and news in the next year. More than I get from most stocks I own, they have 9 ANDA applications, partnership deals working, other countries to partner, new applications, earnings reports, The way I see it they should have a report on average about every month of significance.
I think a lot depends on the general market and how soon news is forthcoming. It could be several months or next week or the market could go down another 1000 points on the DOW. one thing for sure there will be significant news coming in the next year and this price will be a bargain
according to the CC they will use existing facility for expansion for production and get new administrative offices if needed but they can stay were they are for quite awhile from what I heard in the presentation. The rest you heard is what i also heard. The sell off is manipulation by shorts and the market being down and also people like fob access lightening up their holdings because they expected more from the conference call and are losing patience. Gives those of us with a longer time horizon a good opportunity.
IMO think of these items when trying to determine the worth of Rexista oxycodone alone and not other opiates using the following information
1) first out
2) removes drug abuse possibilities
3) oxycontin current sales 2 billion
4) some doctors and dentists won't prescribe current because of drug abuse qualities
5) FDA is pushing to get oxycontin less abused
6) any doctor prescribing once this comes out will likely switch as they would have a liability for prescribing a drug that could be abused vs one that can't, that liability not only being malpractice suits from lawyers but also discipline from medical bds and dental bds if done in large quantities and multiple times.
IF I were a company currently selling oxycontin I would be beating the door down at IPCI to be their partner on this one but they unfortunately are probably not going to be able to get approval on this one til 2016
The bigger one right now IMO that is closer is Seroquel which is a 1.1 billion drug and the reason is they and no other generic have made a deal with the current patent holder Astro and will be the first and only generic on market as of 2016 when astro patent expires if FDA approval comes along wo astro fighting them. The other generics fought in court and lost where IPCI just cut a deal, SMART
I am not sure that it will take a long time, just not tomorrow or next week, there will more than likely be 3 FDA decisions for this company in the next 6 months, 2 new ANDA applications or more in the next 6 months, earnings report in next couple of months with hopefully a little better guidance on Focalin sales( I just wish someone on this board had access to IMS numbers and would report), possible new deals on other countries on Focalin, possible new deals on other drugs in the near term as they are approved, i really see a lot of possible items that could move this in the relative short term (3 to 6 months) and you just never know when they could happen. So much on these posts depends on a persons definition of short term and whether they are long term minded. My main concern right now is a market turn around and an end to this correction.
I don't think that is what is happening, they filed a shelf registration and to do so they put a minimum price as required in it, this was prepared prior to the FDA approval of Focalin XR, it is an ATM so therefore they will as they have stated only sell it when the market price is high enough that they feel it is validated, whether that is 3.16 or $5, of course that will also be determined by their need for funds but they have also stated that currently they have funds coming in from Focalin sales and warrants that are in the money being exercised. The truth is they may not even sell any shares under the ATM in the foreseeable future. i.e. next twelve months.
it depends on your goal, i look at this as another opportunity to buy, if you have a 4 or 5 yr outlook and the price goal i have the small down side is minimal and I am down 11% on more shares than you but can't wait to get more. my goal is in upper double digits. My long term goal is to have this be my first stock to make me 7 figures.
I think the big market is the US and they got their partner for that now they can go after other countries and partners will eventually be easier to find once they see how well Par does or Par may want to add other countries
I am sure you spent that time as I did do some research but got the name of a previous company he worked with as I was lucky just to remember his name. Had you listened to the operator at IPCI you could have gotten the information easier from the CC or had you given your email or phone number to them rather than expect them to wait by the phone for your call. The only reason I remembered his name was while i was waiting for his return call I googled him up and read about him. I googled Swilla but didn't come up with anything useful, sorry. But I did try to help you sorry about the wrong information on where he worked blame Google. I didn't say I tried for an hour to help you I said over an hour period I tried to help you. Do you understand the difference?? But if you are friends with fob access let me know as I can put you where I put him. but your posts are a more enlightening than his. I haven't seen any of his posts that have been useful or positive. Give him time he will call you a name.
if they go to Iran I sell every share I own, that will be a move that tells me the upper echelon is extremely stupid
I look more at the sell off as someone dumping rapidly and with no care for loss then it just came back, I don't see anything special here except the sell off by someone indiscriminately.
look in the mirror #$%$, you do more name calling I just call out stupid which is you. I tried numerous times to help Swilla over an hour period you have done more name calling and stupid comments than anyone on this board you have earned ignore
on Schedule 2 drugs (read rexista) they need an American partner and it has to be manufactured here in the US, In canada they don't have a partner yet only the US for Focalin but they are negotiating for other countries now. It will be in 2014 but they will have more partners but none they fear will take their technology.